Success Stories: EB-1A Approved for Research Fellow in California in the Field of Translational Cancer Research
Client’s Testimonial:
I would like to thank you for your assistance in helping me obtain the EB1A I-140. Your service is very much appreciated. I will recommend you to my friends and colleagues who wishes to use the service.
On March 30th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Fellow in the Field of Translational Cancer Research (Approval Notice)
General Field: Translational Cancer Research
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 30th, 2015
Processing Time: 20 Days (7 Days after Premium Processing Requested)
Case Summary:
In this case, the client that we had the opportunity to work with was a Research Fellow from China in the field of Translational Cancer Research. Her specialized research has focused on pharmaceutical development, with a particular focus on investigating and developing anti-cancer therapies that target various forms of malignant diseases. Her work had resulted in 9 peer-reviewed scientific articles, numerous presentations at national and international conferences, and 5 U.S. patents; at the time that her case was filed, her publications had been cited at least 179 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 11 manuscripts for distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] created a new treatment strategy to protect against gastrointestinal toxicity caused by radiation through inhibiting prolyl hydroxylase. This study adds to public safety in the event of a nuclear disaster, and is of particular importance going forward as the U.S. increases its number of nuclear power plants to generate power.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Translational Cancer Research, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 20 days.